NCT00796653 - Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II | Biotech Hunter

Enrollment

937

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2010

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Olodaterol (BI 1744)

Comparison of low and high doses on efficacy and safety in COPD patients

DRUG

Olodaterol (BI 1744)

Comparison of low and high doses on efficacy and safety in COPD patients

DRUG

Formoterol

Active comparator with Olodaterol (BI 1744) on safety and efficacy in COPD patients

DRUG

Placebo

Placebo devices for comparison with Olodaterol (BI 1744) on safety and efficacy in COPD patients

Trial Locations (98)

Unknown

1222.14.5004 Boehringer Ingelheim Investigational Site, Capital Federal

1222.14.5003 Boehringer Ingelheim Investigational Site, Mar del Plata

1222.14.5001 Boehringer Ingelheim Investigational Site, Mendoza

1222.14.5002 Boehringer Ingelheim Investigational Site, Quilmes

1222.14.5005 Boehringer Ingelheim Investigational Site, San Juan Bautista

1222.14.5106 Boehringer Ingelheim Investigational Site, Florianópolis

1222.14.5101 Boehringer Ingelheim Investigational Site, Porto Alegre

1222.14.5103 Boehringer Ingelheim Investigational Site, Porto Alegre

1222.14.5104 Boehringer Ingelheim Investigational Site, Porto Alegre

1222.14.5102 Boehringer Ingelheim Investigational Site, Recife

1222.14.5105 Boehringer Ingelheim Investigational Site, São Paulo

1222.14.4005 Boehringer Ingelheim Investigational Site, Calgary

1222.14.4002 Boehringer Ingelheim Investigational Site, Kelowna

1222.14.4004 Boehringer Ingelheim Investigational Site, Vancouver

1222.14.4009 Boehringer Ingelheim Investigational Site, Moncton

1222.14.4010 Boehringer Ingelheim Investigational Site, St. John's

1222.14.4008 Boehringer Ingelheim Investigational Site, Grimsby

1222.14.4014 Boehringer Ingelheim Investigational Site, Mississauga

1222.14.4007 Boehringer Ingelheim Investigational Site, Newmarket

1222.14.4013 Boehringer Ingelheim Investigational Site, Ottawa

1222.14.4001 Boehringer Ingelheim Investigational Site, Scarborough Village

1222.14.4012 Boehringer Ingelheim Investigational Site, Montreal

1222.14.4006 Boehringer Ingelheim Investigational Site, Québec

1222.14.4015 Boehringer Ingelheim Investigational Site, Sherbrooke

1222.14.4011 Boehringer Ingelheim Investigational Site, Saskatoon

1222.14.6004 Boehringer Ingelheim Investigational Site, Brno

1222.14.6003 Boehringer Ingelheim Investigational Site, Hradec Králové

1222.14.6002 Boehringer Ingelheim Investigational Site, Kyjov

1222.14.6001 Boehringer Ingelheim Investigational Site, Znojmo

1222.14.4602 Boehringer Ingelheim Investigational Site, Elsinore

1222.14.4601 Boehringer Ingelheim Investigational Site, Hillerød

1222.14.4603 Boehringer Ingelheim Investigational Site, Roskilde

1222.14.4702 Boehringer Ingelheim Investigational Site, Espoo

1222.14.4701 Boehringer Ingelheim Investigational Site, HUS

1222.14.4703 Boehringer Ingelheim Investigational Site, Lohja

1222.14.4106 Boehringer Ingelheim Investigational Site, Aschaffenburg

1222.14.4112 Boehringer Ingelheim Investigational Site, Berlin

1222.14.4103 Boehringer Ingelheim Investigational Site, Frankfurt

1222.14.4110 Boehringer Ingelheim Investigational Site, Frankfurt

1222.14.4108 Boehringer Ingelheim Investigational Site, Gelnhausen

1222.14.4107 Boehringer Ingelheim Investigational Site, Kelkheim

1222.14.4114 Boehringer Ingelheim Investigational Site, Lübeck

1222.14.4111 Boehringer Ingelheim Investigational Site, Mainz

1222.14.4113 Boehringer Ingelheim Investigational Site, Minden

1222.14.4109 Boehringer Ingelheim Investigational Site, Mönchengladbach

1222.14.4104 Boehringer Ingelheim Investigational Site, Rodgau-Dudenhofen

1222.14.4105 Boehringer Ingelheim Investigational Site, Wiesloch

1222.14.5501 Boehringer Ingelheim Investigational Site, Hong Kong

1222.14.5412 Boehringer Ingelheim Investigational Site, Coimbatore

1222.14.5406 Boehringer Ingelheim Investigational Site, Hyderabad

1222.14.5402 Boehringer Ingelheim Investigational Site, Indore

1222.14.5405 Boehringer Ingelheim Investigational Site, Jaipur

1222.14.5409 Boehringer Ingelheim Investigational Site, Jaipur

1222.14.5403 Boehringer Ingelheim Investigational Site, Mangalore

1222.14.5407 Boehringer Ingelheim Investigational Site, Mysore

1222.14.5404 Boehringer Ingelheim Investigational Site, Nagpur

1222.14.5408 Boehringer Ingelheim Investigational Site, Noida

1222.14.5401 Boehringer Ingelheim Investigational Site, Pune

1222.14.5410 Boehringer Ingelheim Investigational Site, Vellore

1222.14.4301 Boehringer Ingelheim Investigational Site, Cassano Delle Murge (ba)

1222.14.4302 Boehringer Ingelheim Investigational Site, Genova

1222.14.4304 Boehringer Ingelheim Investigational Site, Milan

1222.14.4305 Boehringer Ingelheim Investigational Site, Parma

1222.14.4303 Boehringer Ingelheim Investigational Site, Roma

1222.14.5701 Boehringer Ingelheim Investigational Site, Georgetown, Pulau Pinang

1222.14.5703 Boehringer Ingelheim Investigational Site, Kuala Lumpur

1222.14.5702 Boehringer Ingelheim Investigational Site, Kuching, Sarawak

1222.14.4802 Boehringer Ingelheim Investigational Site, Fredrikstad

1222.14.4801 Boehringer Ingelheim Investigational Site, Ski

1222.14.5802 Boehringer Ingelheim Investigational Site, Iloilo City

1222.14.5803 Boehringer Ingelheim Investigational Site, Iloilo City

1222.14.5801 Boehringer Ingelheim Investigational Site, Manila

1222.14.6103 Boehringer Ingelheim Investigational Site, Brasov

1222.14.6102 Boehringer Ingelheim Investigational Site, Constanța

1222.14.6101 Boehringer Ingelheim Investigational Site, Iași

1222.14.6203 Boehringer Ingelheim Investigational Site, Petrozavodsk

1222.14.6201 Boehringer Ingelheim Investigational Site, Saint Petersburg

1222.14.6202 Boehringer Ingelheim Investigational Site, Saint Petersburg

1222.14.4901 Boehringer Ingelheim Investigational Site, Cape Town

1222.14.4902 Boehringer Ingelheim Investigational Site, Cape Town

1222.14.5301 Boehringer Ingelheim Investigational Site, Bucheon-si

1222.14.5302 Boehringer Ingelheim Investigational Site, Seoul

1222.14.5305 Boehringer Ingelheim Investigational Site, Seoul

1222.14.5306 Boehringer Ingelheim Investigational Site, Seoul

1222.14.5304 Boehringer Ingelheim Investigational Site, Uijeongbu-si

1222.14.5303 Boehringer Ingelheim Investigational Site, Wŏnju

1222.14.4401 Boehringer Ingelheim Investigational Site, Barcelona

1222.14.4402 Boehringer Ingelheim Investigational Site, Barcelona

1222.14.4406 Boehringer Ingelheim Investigational Site, Madrid

1222.14.4405 Boehringer Ingelheim Investigational Site, Mérida

1222.14.4403 Boehringer Ingelheim Investigational Site, Palma de Mallorca

1222.14.4407 Boehringer Ingelheim Investigational Site, Terrassa (Barcelona)

1222.14.4501 Boehringer Ingelheim Investigational Site, Boden

1222.14.4503 Boehringer Ingelheim Investigational Site, Göteboerg

1222.14.4502 Boehringer Ingelheim Investigational Site, Lund

1222.14.5904 Boehringer Ingelheim Investigational Site, Bangkok

1222.14.5901 Boehringer Ingelheim Investigational Site, Khon Kaen

1222.14.5902 Boehringer Ingelheim Investigational Site, Songkhla